NCT01038869View on ClinicalTrials.gov

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Acne VulgarisPost Inflammatory Hyperpigmentation
Interventions
DRUG

Azelaic acid

Apply sparingly to the face twice a day (morning and night). Massage gently into the skin until vanishing. Approximately 0.5g (2.5cm strip) is sufficient for the entire facial area.

Trial Locations (1)

40217

DermResearch, PLLC, Louisville

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Derm Research, PLLC

OTHER

NCT01038869 - Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) | Biotech Hunter | Biotech Hunter